238 related articles for article (PubMed ID: 33202944)
21. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
22. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
23. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.
Muñoz-Galván S; Felipe-Abrio B; García-Carrasco M; Domínguez-Piñol J; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sánchez A; Navas LE; Otero-Albiol D; Marin JJ; Jiménez-García MP; García-Heredia JM; Quiroga AG; Estevez-Garcia P; Carnero A
J Exp Clin Cancer Res; 2019 Jun; 38(1):234. PubMed ID: 31159852
[TBL] [Abstract][Full Text] [Related]
24. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
25. Understanding melanoma stem cells.
Nguyen N; Couts KL; Luo Y; Fujita M
Melanoma Manag; 2015; 2(2):179-188. PubMed ID: 26594315
[TBL] [Abstract][Full Text] [Related]
26. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
Doherty RE; Sisley K; Hammond DW; Rennie IG; Cross NA
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5387-5395. PubMed ID: 29049740
[TBL] [Abstract][Full Text] [Related]
28. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
[TBL] [Abstract][Full Text] [Related]
29. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
30. Expression of cancer stem cell markers in metastatic melanoma to the brain.
Wickremesekera AC; Brasch HD; Lee VM; Davis PF; Woon K; Johnson R; Tan ST; Itinteang T
J Clin Neurosci; 2019 Feb; 60():112-116. PubMed ID: 30626524
[TBL] [Abstract][Full Text] [Related]
31. Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Kumar S; Mehta K
Amino Acids; 2013 Jan; 44(1):81-8. PubMed ID: 22083892
[TBL] [Abstract][Full Text] [Related]
32. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
De Angelis ML; Francescangeli F; Zeuner A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Adaptations in Cancer Stem Cells.
Yadav UP; Singh T; Kumar P; Sharma P; Kaur H; Sharma S; Singh S; Kumar S; Mehta K
Front Oncol; 2020; 10():1010. PubMed ID: 32670883
[TBL] [Abstract][Full Text] [Related]
34. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
35. Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells.
Li H; Chen J; Wang X; He M; Zhang Z; Cen Y
Oncol Rep; 2018 Jun; 39(6):2855-2864. PubMed ID: 29693169
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
37. Human endogenous retroviruses role in cancer cell stemness.
Matteucci C; Balestrieri E; Argaw-Denboba A; Sinibaldi-Vallebona P
Semin Cancer Biol; 2018 Dec; 53():17-30. PubMed ID: 30317035
[TBL] [Abstract][Full Text] [Related]
38. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
[TBL] [Abstract][Full Text] [Related]
39. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
